Anti-DNAJA4 monoclonal antibody

Pre-made anti-DNAJA4 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to DNAJA4/DNAJA4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2458-Ab-1/ GM-Tg-hg-IP2458-Ab-2Anti-Human DNAJA4 monoclonal antibodyHuman
GM-Tg-rg-IP2458-Ab-1/ GM-Tg-rg-IP2458-Ab-2Anti-Rat DNAJA4 monoclonal antibodyRat
GM-Tg-mg-IP2458-Ab-1/ GM-Tg-mg-IP2458-Ab-2Anti-Mouse DNAJA4 monoclonal antibodyMouse
GM-Tg-cynog-IP2458-Ab-1/ GM-Tg-cynog-IP2458-Ab-2Anti-Cynomolgus/ Rhesus macaque DNAJA4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2458-Ab-1/ GM-Tg-felg-IP2458-Ab-2Anti-Feline DNAJA4 monoclonal antibodyFeline
GM-Tg-cang-IP2458-Ab-1/ GM-Tg-cang-IP2458-Ab-2Anti-Canine DNAJA4 monoclonal antibodyCanine
GM-Tg-bovg-IP2458-Ab-1/ GM-Tg-bovg-IP2458-Ab-2Anti-Bovine DNAJA4 monoclonal antibodyBovine
GM-Tg-equg-IP2458-Ab-1/ GM-Tg-equg-IP2458-Ab-2Anti-Equine DNAJA4 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2458-Ab-1/ GM-Tg-hg-IP2458-Ab-2; GM-Tg-rg-IP2458-Ab-1/ GM-Tg-rg-IP2458-Ab-2;
GM-Tg-mg-IP2458-Ab-1/ GM-Tg-mg-IP2458-Ab-2; GM-Tg-cynog-IP2458-Ab-1/ GM-Tg-cynog-IP2458-Ab-2;
GM-Tg-felg-IP2458-Ab-1/ GM-Tg-felg-IP2458-Ab-2; GM-Tg-cang-IP2458-Ab-1/ GM-Tg-cang-IP2458-Ab-2;
GM-Tg-bovg-IP2458-Ab-1/ GM-Tg-bovg-IP2458-Ab-2; GM-Tg-equg-IP2458-Ab-1/ GM-Tg-equg-IP2458-Ab-2
Products NameAnti-DNAJA4 monoclonal antibody
Formatmab
Target NameDNAJA4
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-DNAJA4 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2458-Ag-1Recombinant multi-species DNJA4/ DNAJA4/ MST104 protein
    ORF Viral VectorpGMLPm001682mouse Dnaja4 Lentivirus plasmid
    ORF Viral VectorvGMLPm001682mouse Dnaja4 Lentivirus particle


    Target information

    Target IDGM-IP2458
    Target NameDNAJA4
    Gene ID55466,58233,300721,709872,488777,101091198,528615,100060143
    Gene Symbol and Synonyms1110021L12Rik,Dj4,DNAJA4,Hsj4,mmDjA4,MST104,MSTP104,PRO1472
    Uniprot AccessionQ8WW22
    Uniprot Entry NameDNJA4_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000140403
    Target ClassificationN/A

    The target: DNAJA4, gene name: DNAJA4, also named as MST104, MSTP104, PRO1472. Enables chaperone binding activity and unfolded protein binding activity. Involved in several processes, including negative regulation of endothelial cell migration; negative regulation of inclusion body assembly; and protein refolding. Located in cytosol and membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.